Skip to main content

J&J Expects to Have 600-800 Million COVID-19 Vaccines by 2021

Author:
Video Duration:
0
Image placeholder title
Economics

J&J inks 2nd manufacturing deal to boost capacity for COVID-19 vaccine

Image placeholder title
Science

FDA Approves Saliva Based COVID-19 Test

Image placeholder title
Science

Former FDA Exec Says Pandemic Could End in 2021 With Pfizer and Moderna Vaccines

Image placeholder title
Science

Researchers Develop Mask that Can Determine if Wearer Has COVID-19

Image placeholder title
Science

Epidemiologist Says COVID-19 Is Increasing the Mental Health Crisis

Image placeholder title
Science

Researchers Believe a Hyperactive Immune System Might be Deadlier Than COVID-19

Image placeholder title
Science

Pfizer and BioNTech Vaccine Candidate is 90% Effective

Image placeholder title
Science

OSU Medical Center Scientists Create Solution Approved by FDA for COVID-19 Test

Image placeholder title
Economics

Wharton Professor Jeremy Siegel Believes Covid-19 Vaccine Will Be Here Soon